August 1, 2017August 1, 2017

Inventiva to Release Novel Data on Anti-fibrotic Product, IVA337, at Scleroderma Workshop

News

French pharmaceutical firm Inventiva will present novel data on its new anti-fibrotic product, IVA337, during the 15th International Workshop on Scleroderma Research, to be held Aug. 5-9 at the University of Pittsburgh. ... Read more

February 29, 2016March 16, 2016

Inventiva, Developer of Potential Therapy for Systemic Sclerosis, Awarded at 4th World Congress for Its Innovative Approach

Idiopathic Pulmonary Fibrosis, News, Scleroderma

Inventiva, a drug discovery company focused on the treatments of fibrotic, oncological, and rare diseases, announced that the organizing committee of the 4th Systemic Sclerosis World Congress in Lisbon, Portugal, which ... Read more